— Know what they know.
Not Investment Advice

SOLV NYSE

Solventum Corporation
1W: +1.0% 1M: -4.1% 3M: -0.3% YTD: +8.7% 1Y: +18.8%
$82.98
-2.83 (-3.30%)
After Hours: $83.69 (+0.70, +0.85%)
Weekly Expected Move ±2.8%
$81 $83 $85 $88 $90
NYSE · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 48 · $14.1B mcap · 144M float · 0.760% daily turnover · Short 57% of daily vol
Credit Risk of going bust: lower than 68% of companies Debt: 26.6% of company value Bonds: $164.5M held by 298 funds, 78 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.97 (down 98%), Solventum Corporation would be worth roughly what it owes.
Total debt $5.29B against a stock market value of $14.61B.
Distance to default 7.31 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.79B (short-term plus half of long-term), stock volatility 29.7%; Altman Z 2.16. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Balance Sheet Trends

Total Assets
$14.3B -1.1% ▼
4Y CAGR: +0.4%
Total Liabilities
$9.2B -19.6% ▼
4Y CAGR: +46.3%
Shareholders Equity
$5.0B +70.6% ▲
4Y CAGR: -19.6%
Cash & Investments
$878M +15.2% ▲
4Y CAGR: +76.2%
Total Debt
$5.0B -37.1% ▼
Net Debt
$4.2B -42.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$91M$61M$194M$762M$878M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$91M$61M$194M$762M$878M
Net Receivables$1.2B$1.2B$1.3B$1.2B$1.0B
Inventory$813M$873M$857M$965M$1.1B
Other Current Assets$108M$126M$155M$293M$881M
Total Current Assets$2.2B$2.2B$2.5B$3.2B$3.9B
Property, Plant & Equip.$1.3B$1.3B$1.5B$1.6B$1.3B
Goodwill & Intangibles$10.3B$9.7B$9.4B$8.9B$8.3B
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$253M$358M$530M$665M$813M
Total Non-Current Assets$11.9B$11.4B$11.4B$11.2B$10.4B
Total Assets$14.1B$13.6B$13.9B$14.5B$14.3B
— Liabilities —
Accounts Payable$320M$348M$477M$618M$687M
Short-Term Debt$0$0$0$200M$0
Deferred Revenue$574M$559M$574M$572M$621M
Other Current Liabilities$323M$236M$365M$659M$1.8B
Total Current Liabilities$1.4B$1.3B$1.7B$2.7B$3.1B
Long-Term Debt$0$0$8.3B$7.8B$5.0B
Other Non-Current Liab.$392M$326M-$8.0B$760M$910M
Total Non-Current Liabilities$610M$541M$549M$8.8B$6.1B
Total Liabilities$2.0B$1.9B$2.3B$11.5B$9.2B
— Equity —
Common Stock$0$0$0$2M$2M
Retained Earnings$0$0$0$242M$1.8B
Accumulated OCI-$200M-$497M-$337M-$1.1B-$625M
Total Stockholders Equity$12.1B$11.7B$11.7B$3.0B$5.0B
Total Liabilities & Equity$14.1B$13.6B$13.9B$14.5B$14.3B
— Key Metrics —
Total Debt$0$0$8.3B$8.0B$5.0B
Net Debt-$91M-$61M$8.1B$7.2B$4.2B
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms